The burden of chronic diseases is rapidly increasing across the world. Change in lifestyle is the major factor leading to many chronic diseases such as cancer. The World Health Organization (WHO) has estimated chronic disease prevalence to rise by 57% by the end of 2020.
With the rise in chronic diseases, there is increasing demand for healthcare systems to focus more on effective treatment for the same. Furthermore, rising demand for biopharmaceutical and biotechnological products, which has increased spending on cell culture development, is anticipated boost the growth of the cell culture media market over the coming years.
Find Out More about the Report Coverage
- Thermo Fisher Scientific Inc.
- Merck KGaA
- GE Healthcare
- Corning Incorporated
- Irvine Scientific
- STEMCELL Technologies Inc.
- PAN Biotech
- MP Biomedicals, LLC
- PromoCell GmbH
- Becton, Dickinson and Company
- Hi-Media Laboratories
Increasing Production of Antibodies for Disease Treatment Aiding Market Growth
Cell culture technology using various culture media has been proven to be a reliable and robust technology. Cell culture technology can help in the development of monoclonal antibodies. These antibodies can be produced synthetically using cell culture media in laboratories.
Monoclonal antibodies have been used as therapeutics against various autoimmune diseases, as the body lacks the function of producing monoclonal antibodies.
Hence, increasing demand for monoclonal antibodies as a therapeutic agent using various cell culture media will fuel the growth of the cell culture media market.
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Rising Number of Parenteral Products in Pipeline
There has been a significant rise in parenteral drugs in the pipeline. As per reports, there was a rise of around 55% of parenteral drugs in the pipeline in 2019 when compared to the previous year.
Rise in parenteral products in the pipeline is indicative of the growing demand for cell culture media. Increase in demand for biopharmaceutical products will drive the growth of the cell culture media market through 2029.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
North America and Europe to Lead Cell Culture Media Market
North America and Europe hold a large revenue share of the global cell culture media market, owing to the rising diagnosis and treatment of chronic diseases in these regions. According to WHO, chronic diseases will increase from 3.78 million in 1990 to an expected 7.63 million by the end of 2020.
Increased R&D investments, government initiatives for imparting awareness about cell-culture based vaccines, and rise in healthcare spending are some of the factors that are driving the growth of the cell culture media market in these regions.
However, the significantly large patient pool in the Asia Pacific regions will offer potential growth opportunities for players in the cell culture media market.
Explore Persistence Market Research’s expertise in promulgation of the business !
Competitive Landscape of Cell Culture Media Market
The cell culture media market is consolidated in nature, with the top 5 players holding over 65% of the market share in 2018. Collaborations with pharmaceutical product manufacturers remains the main focus of players that only offer cell culture media.
However, many players are focused on developing in-house cell culture media platforms to offer unique and cost-effective cell culture media products. Other players are focused on geographical expansion through distribution agreements.
For instance, in May 2017, Lonza acquired cell and gene contract manufacturer - Pharma Cell - to enhance its production capability and reach.
A majority of companies are expanding their business by increasing collaborations between contract manufacturing organizations and key players. Other players are focusing on increasing their product portfolios. Based on this trend, North America and Europe will hold substantial share of the global cell culture media market through 2029. Cost-effective and enhanced cell culture media will favor market growth. Increased funding for research & development toward drug development will help the cell culture media market grow at a substantial rate. However, at the same time, the high cost of R&D and concerns about sterility will hamper market growth to some extent. There will also be some failure of drugs in pipeline analysis.
Key Segments of Cell Culture Media Market
PMR’s study on the cell culture media market offers information divided into four important segments — product, application, end user and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories
Key Questions Answered in PMR’s Cell Culture Media Market Report
- Which regions will continue to remain the most profitable regional markets for cell culture media market players?
- Which factors will induce a change in the demand for cell culture media during the assessment period?
- What are the different opportunities available for emerging players in the cell culture media market?
- How are supply-side and demand-side drivers impacting the cell culture media market?
- How will changing trends impact the cell culture media market?
- How can market players capture the low-hanging opportunities in the cell culture media market in developed regions?
- Which companies are leading the cell culture media market?
- What are the winning strategies of stakeholders in the cell culture media market to upscale their position in this landscape?